Tag: hepzato kit
Delcath Systems receives US FDA authorisation for Hepzato phase two clinical...
Delcath Systems has announced that the US Food and Drug Administration (FDA) has completed its 30-day review of the company's investigational new drug (IND)...
Delcath Systems announce first commercial use of Hepzato Kit
Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, has announced the first commercial use...
Delcath Systems announces additional funding for Hepzato Kit FDA approval
Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, has announced that it raised approximately...
Delcath Systems announces new drug application resubmission for Hepzato Kit
Delcath Systems has announced it has submitted a new drug application (NDA) resubmission to the US Food and Drug Administration (FDA) for the Hepzato...
